Ivermectin is a sixteen-membered macrolide derivative, which is semi-synthesized from avermectin fermented by Streptomyces vermiculum. It belongs to the compound of avermectin, containing ivermectin B1 ( Bla B1b) not less than 93%, of which Bla must not be less than 85%. Ivermectin B1 is 22,23-dihydroabamectin B1. Ivermectin is a dual drug for humans and animals.
Product Description
Jiayi Pharmaceutical is proud to introduce its latest product, Ivermectin EP Standard. Ivermectin is a broad-spectrum antiparasitic agent that has been used for over 30 years to treat various parasitic infections. Ivermectin EP Standard is a high-quality product that is manufactured in compliance with the European Pharmacopoeia (EP) Standard, ensuring its purity and efficacy.
Ivermectin EP standard refers to the European Pharmacopoeia (EP) standard for the drug Ivermectin. The European Pharmacopoeia is a collection of legally binding quality standards for medicines used in Europe, and Ivermectin is included in this collection.
The EP standard for Ivermectin specifies the chemical and physical properties of the drug, as well as the quality control tests that must be performed to ensure that it meets the required standards. This includes tests for impurities, potency, and microbiological quality.
The EP standard for Ivermectin is used by pharmaceutical manufacturers and regulatory agencies in Europe to ensure the quality, safety, and efficacy of medicines containing Ivermectin. It is important to note that the EP standard is specific to Europe, and other regions may have different standards or regulations for Ivermectin or other drugs.
View relevant certificates now
Ivermectin is a sixteen-membered macrolide derivative, which is semi-synthesized from avermectin fermented by Streptomyces vermiculum. It belongs to the compound of avermectin, containing ivermectin B1 ( Bla B1b) not less than 93%, of which Bla must not be less than 85%. Ivermectin B1 is 22,23-dihydroabamectin B1. Ivermectin is a dual drug for humans and animals.
Ivermectin is a broad-spectrum antiparasitic drug, and is the first choice for human anti-intestinal parasitic drugs. It was registered for human use in 1987 and was donated for the treatment of onchocerciasis and lymphatic filariasis. Since the implementation of this large-scale drug donation project, it has helped 1.5 billion people in total. According to the latest data, about 186 million people worldwide still need treatment every year, and about 112 million people can obtain medicines, mainly in the African region.
As a powerful anthelmintic and insecticide in veterinary medicine, ivermectin was launched in 1981 and was quickly used in the global livestock industry to resist nematodes and other various infections. Treat cattle, sheep, horses, and pigs to treat digestive tract ciliates, pulmonary ciliates, endoparasitic arthropods, and gastrointestinal ciliates in dogs.
Ivermectin CAS#: 70288-86-7, the quality standard meets the latest version of EP, the packaging specification is 25kg/barrel, or customized by customers. Jiayi has DMF/veterinary drug GMP and is a veterinary drug GMP factory.
►High Quality: Ivermectin EP Standard is produced using the highest quality raw materials and manufactured in compliance with the EP Standard, ensuring its purity and effectiveness.
►Broad-Spectrum Action: Ivermectin is effective against a broad range of parasites, including nematodes, mites, and lice. It is used to treat infections such as onchocerciasis (river blindness), strongyloidiasis, scabies, and head lice.
►Safe and Effective: Ivermectin has been used for over 30 years and is considered a safe and effective treatment for parasitic infections. It has been approved by regulatory bodies around the world, including the FDA in the United States.
►Easy to Use: Ivermectin EP Standard is available in various forms, including tablets, oral solutions, and creams. This makes it easy to use and administer, depending on the specific needs of the patient.
►Cost-Effective: Jiayi Company's Ivermectin EP Standard is an affordable solution for the treatment of parasitic infections. It provides a cost-effective alternative to other treatments that may be more expensive.
Ivermectin EP Standard is used in the treatment of various parasitic infections, including:
•Onchocerciasis (river blindness)
•Strongyloidiasis
•Scabies
•Head lice
Ivermectin EP Standard is suitable for use in both humans and animals.
Jiayi Company's Ivermectin EP Standard is a high-quality, safe, and effective treatment for parasitic infections. It is manufactured in compliance with the EP Standard and is available in various forms for ease of use. With its broad-spectrum action and affordability, Ivermectin EP Standard is an excellent choice for the treatment of parasitic infections.
Sign In